Content of Reports. ▇▇▇▇▇▇ will provide to Cadence reports containing the data, test results, and specifications or procedures for the Product developed specifically for the Compound and/or the Formulation (“API/Formulation Specifications”), as described in any Development Plan, which, collectively with the ▇▇▇▇▇▇ Development Deliverables, shall be referred to herein as the “Reports.” The Reports may also contain references to (i) ▇▇▇▇▇▇ standard operating procedures, specifications, material codes and their specifications, and other information developed by ▇▇▇▇▇▇ prior to the Original Effective Date, but not including any such procedures, specifications, material codes and their specifications or other information developed by ▇▇▇▇▇▇ in its Grosotto facility and which is owned or licensed to the licensor of Cadence Licensed Intellectual Property (“Preexisting Specifications”) that fall within ▇▇▇▇▇▇ Background Intellectual Property Rights and (ii) original laboratory notebooks and other Good Laboratory Practices documentation generated by ▇▇▇▇▇▇ or its agents pursuant to this Agreement or the Original Agreement (“Original Product Data”).
Appears in 1 contract
Sources: Development and Supply Agreement (Cadence Pharmaceuticals Inc)
Content of Reports. ▇B▇▇▇▇▇ will provide to Cadence reports containing the data, test results, and specifications or procedures for the Product developed specifically for the Compound and/or the Formulation (“API/Formulation Specifications”), all as described in any Development Plan, which, collectively with detail under the ▇▇▇▇▇▇ Development Deliverables, shall be referred to herein as the heading “Reports.” in the Development Deliverables set forth in Exhibit B The Reports may also contain references to (i) ▇pre-existing B▇▇▇▇▇ standard operating procedures, specifications, material codes and their specifications, and other information developed by ▇B▇▇▇▇▇ prior to the Original Effective Dateexecution of this Agreement, but not including any such procedures, specifications, material codes and their specifications or other information developed by ▇B▇▇▇▇▇ in its Grosotto facility and which is owned or licensed to the licensor of Cadence Licensed Intellectual Property (“Preexisting Pre-Existing Specifications”) that fall within ▇B▇▇▇▇▇ Background Intellectual Property Rights and (ii) original laboratory notebooks and other Good Laboratory Practices documentation generated by ▇B▇▇▇▇▇ or its agents pursuant to this Agreement or the Original Agreement (“Original Product Data.”).
Appears in 1 contract
Sources: Development and Supply Agreement (Cadence Pharmaceuticals Inc)